aiv infeqcia/SidsiT avadmyofTa mkurnaloba da movla (klinikuri ...
aiv infeqcia/SidsiT avadmyofTa mkurnaloba da movla (klinikuri ... aiv infeqcia/SidsiT avadmyofTa mkurnaloba da movla (klinikuri ...
* saWiroa arv preparatebis bavSvebisaTvis misaReb samkurnalwamlo formebSi miwodeba (Txevad formaSi, 6 welze patara bavSvebSi), romelic uzrunvelyofs zust dozirebas. ** anemiis mqone bavSvebSi ukunaCvenebia zidovudinis Semcveli arT sqemebi. *** 3 welze didi asakis bavSvebSi **** arT unda daviwyoT 2 Tviani intensiuri antituberkulozuri Terepiis Semdeg. Tu situacia saSualebas gavaZlevs arT umjobesia daviwyoT antituberkulozuri Terapiis kursis damTavrebisas. es Tavidan agvacilebs rifampicinisa da arv preparatis negatiuri urTierTqmedebis Sedegebs. garda amisa arT da antituberkulozuri preparatebis erTdrouli daniSvna zrdis Terapiis reJimis darRvevis risks. arT-s adreuli daniSvna gamarTlebulia, Tu tuberkuloziT daavadebul aiv inficirebul bavSvs aReniSneba aiv infeqciis gamoxatuli gamovlinebebi an/da mZime imunodeficiti. arT sqemis Secvlis aucilebloba ganpirobebulia an Terapiis araefeqturobiT, an SeuTavsebeli gverdiTi movlenebiT. sqema unda Secvalos im eqimma, romelmac daniSna pirveladi mkurnaloba. vidre axal sqemas davniSnavT unda davrwmundeT, rom bavSvi preparatebs Rebulobda mkacrad daniSnulebis mixedviT. Tu arT-s sqemis gamocvla ganpirobebulia Terapiis araefeqturobiT, saWiroa samive preparatis erTdrouli Secvla meore rigis arT sqema arT-s sawyisi sqema meore rigis rekomendebuli sqema zidovudini + lamivudini + nevirapini an zidovudini + lamivudini + ifavirenci zidovudini + lamivudini + nelfinaviri an zidovudini + lamivudini + lopinaviri/ritonaviri abakaviri + didanozini + lopinaviri/ritonaviri an abakaviri + didanozini + nelfinaviri abakaviri + didanozini + nevirapini an abakaviri + didanozini + efavirenzi * Tu bavSvs SeuZlia kafsulis gadaylapva, xolo preparatis erTjerad doza (romelic gaTvlilia wonaze an sxeulis farTobze) Seadgens ramodenime kafsulas erTad, mas aseve SegviZlia davuniSnoT seqvinavir/ritonaviri an indinavir/ritonaviri 6.reabilitacia da dakvirveba monitoringi samizneebi Semowmebis vada anTropometruli monacemebi Semowmeba laboratoriuli gamokvlevebi 142
pirveli Semowmeba meore Semowmeba momdevno Semowmebebi arT-s dawyebidan 2 kviraSi + + pirveli Semowmebidan erT TveSi + + yovel 3 TveSi, Tu saWiro ar aris ufro xSiri vizitebi + + sisxlis klinikuri analizi, RviZlis fermentebis aqtivoba; Sardis saerTo analizi sisxlis klinikuri analizi, RviZlis fermentebis aqtivoba; Sardis saerTo analizi sisxlis klinikuri analizi, RviZlis fermentebis aqtivoba. CD4-is dones sazRvraven yovel 3-4 TveSi, Tu ar aris Cveneba ufro xSiri gamokvlevisaTvis 1 Tu sqema Seicavs nevirapins, 18 Tvis ganmavlobaSi, yovel 4 TveSi unda ganvsazRvroT RviZlis funqciuri maCveneblebi. arT-s efeqturobis kontroli klinikuri maCveneblebis kontroli (sigrZe, wona, saerTo mdgomareoba) janmrTeli bavSvis fizikuri ganviTareba mudmivad mimdinareobs da wonisa da simaRlis matebiT gamovlindeba. imunodeficitis mqone aiv inficirebul bavSvebSi igi Seferxebulia da arT-s dawyebis fonze mkveTrad matulobs. qvemoT mocemulia ZiriTadi klinikuri maCvenebebi, romlebic saSualebas mogvcems vimsjelod arT-s efeqtianobaze. • “wona/simaRlis” diagrama (rodesac SeuZlebelia CD4-is donis gansazRvra, mkurnalobis efeqtianobis Sesafaseblad gamoiyeneba fizikur ganviTarebis diagramebi). Tu im bavSvebis ganviTarebis fizikuri maCveneblebi, romlebsac utardebaT arT, ar Seesabameba diagramebze mocemul maCveneblebs, unda veZeboT ganviTarebis Seferxebis mizezebi. ZiriTadi mizezi oria: − oportunistuli infeqcia (am SemTxvevaSi diagramis mrudi mkveTrad ecema). − Terapiis reJimis darRveva (am SemTxvevaSi diagramis mrudi ecema TandaTanobiT). • fsiqomotoruli ganviTareba • nevrologiuri darRvevebi, maT Soris encefalopaTiis simptomebi. • infeqciuri daavadebebi: saxe da sixSire. 143
- Page 92 and 93: qimioTerapiiT (mag : B-ALL reJimi)
- Page 94 and 95: • imunodeficitis mqone pacientebS
- Page 96 and 97: an famcikloviri 500 mg 3-jer dReSi
- Page 98 and 99: • berkitis-tipis limfoma; • naz
- Page 100 and 101: 3.2.2. cxeleba aiv inficirebulebSi
- Page 102 and 103: afTozuri wylulebi stomatiti qeiliti
- Page 104 and 105: ganmavlobaSi 2 Tvis manZilze (xelis
- Page 106 and 107: o gamonayari warmodgenilia mravlobi
- Page 108 and 109: 20. Chen XM et al. Cryptosporidiosi
- Page 110 and 111: Tavi IV. aiv infeqcia/SidsiT daavad
- Page 112 and 113: inficirebul bavSvebSi (ramdenadac a
- Page 114 and 115: 8 igulisxmeba piri, romelsac aReniS
- Page 116 and 117: 4.3. daxocili da inaqtivirebuli vaq
- Page 118 and 119: kerebSi A hepatiti erTeuli an mcire
- Page 120 and 121: 13 riski maRalia staJirebis periodS
- Page 122 and 123: ganmavlobaSi, xolo SedarebiT ufro s
- Page 124 and 125: 4.8. tkipismieri encefalitis vaqcin
- Page 126 and 127: CvenebebiTa da doziT, rogorc imunok
- Page 128 and 129: 4.11.2.3. cofis sawinaaRmdego imuno
- Page 130 and 131: ekomendebulia: vaqcina rekomendebul
- Page 132 and 133: 8. United States Centers for Diseas
- Page 134 and 135: aiv infeqcia/Sidsis antiretrovirusu
- Page 136 and 137: 5. mkurnaloba a) rekomendebuli pirv
- Page 138 and 139: aiv infeqcia/SidsiT daavadebuli bav
- Page 140 and 141: joxiseburi TiTebi. Tumca wlebis man
- Page 144 and 145: laboratoriuli monacemebis kontroli
- Page 146 and 147: Tirkmlis funqciuri sinjebi, gulmker
- Page 148 and 149: aiv infeqcia/Sidsis fonze ganviTare
- Page 150 and 151: aiv infeqcia/Sidsis fonze ganviTare
- Page 152 and 153: 6. reabilitacia da dakvirveba monit
- Page 154 and 155: kandidozuri ezofagitis SemTxvevebSi
- Page 156 and 157: aiv infeqcia/Sidsis fonze ganviTare
- Page 158 and 159: aiv infeqcia/Sidsis fonze ganviTare
- Page 160 and 161: aiv infeqcia/Sidsis fonze ganviTare
- Page 162 and 163: aiv infeqcia/Sidsis fonze ganviTare
- Page 164 and 165: aiv infeqcia/Sidsis fonze ganviTare
- Page 166 and 167: aiv infeqcia/Sidsis fonze ganviTare
- Page 168 and 169: martivi herpesvirusuli infeqciis mZ
- Page 170 and 171: meTodiT, sisxlis saerTo analizi, Rv
- Page 172 and 173: )gamomricxavi _ aiv infeqcia/Sidsis
- Page 174 and 175: aiv infeqcia/Sidsis fonze ganviTare
- Page 176 and 177: aiv infeqcia/Sidsis fonze ganviTare
- Page 178 and 179: aiv infeqcia/Sidsis fonze ganviTare
- Page 180 and 181: aiv infeqcia/Sidsis fonze ganviTare
- Page 182 and 183: aiv infeqcia/Sidsis fonze ganviTare
- Page 184 and 185: aiv infeqcia/Sidsis fonze ganviTare
- Page 186 and 187: aiv infeqcia/SidsiT avadmyofebSi B
- Page 188 and 189: dinamikaSi dakvirveba CD4≥500/mm
- Page 190 and 191: HBV mkurnalobis efeqturoba HBeAg (+
* saWiroa arv preparatebis bavSvebisaTvis misaReb samkurnalwamlo<br />
formebSi miwodeba (Txevad formaSi, 6 welze patara bavSvebSi),<br />
romelic uzrunvelyofs zust dozirebas.<br />
** anemiis mqone bavSvebSi ukunaCvenebia zidovudinis Semcveli arT sqemebi.<br />
*** 3 welze didi asakis bavSvebSi<br />
**** arT un<strong>da</strong> <strong>da</strong>viwyoT 2 Tviani intensiuri antituberkulozuri Terepiis<br />
Semdeg. Tu situacia saSualebas gavaZlevs arT umjobesia <strong>da</strong>viwyoT<br />
antituberkulozuri Terapiis kursis <strong>da</strong>mTavrebisas. es Tavi<strong>da</strong>n<br />
agvacilebs rifampicinisa <strong>da</strong> arv preparatis negatiuri urTierTqmedebis<br />
Sedegebs. gar<strong>da</strong> amisa arT <strong>da</strong> antituberkulozuri preparatebis<br />
erTdrouli <strong>da</strong>niSvna zrdis Terapiis reJimis <strong>da</strong>rRvevis risks. arT-s<br />
adreuli <strong>da</strong>niSvna gamarTlebulia, Tu tuberkuloziT <strong>da</strong>avadebul <strong>aiv</strong><br />
inficirebul bavSvs aReniSneba <strong>aiv</strong> infeqciis gamoxatuli gamovlinebebi<br />
an/<strong>da</strong> mZime imunodeficiti.<br />
arT sqemis Secvlis aucilebloba ganpirobebulia an Terapiis araefeqturobiT,<br />
an SeuTavsebeli gverdiTi movlenebiT. sqema un<strong>da</strong> Secvalos im eqimma,<br />
romelmac <strong>da</strong>niSna pirveladi <strong>mkurnaloba</strong>. vidre axal sqemas <strong>da</strong>vniSnavT<br />
un<strong>da</strong> <strong>da</strong>vrwmundeT, rom bavSvi preparatebs Rebulob<strong>da</strong> mkacrad<br />
<strong>da</strong>niSnulebis mixedviT. Tu arT-s sqemis gamocvla ganpirobebulia Terapiis<br />
araefeqturobiT, saWiroa samive preparatis erTdrouli Secvla<br />
meore rigis arT sqema<br />
arT-s sawyisi sqema<br />
meore rigis rekomendebuli sqema<br />
zidovudini + lamivudini + nevirapini<br />
an<br />
zidovudini + lamivudini +<br />
ifavirenci<br />
zidovudini + lamivudini +<br />
nelfinaviri<br />
an<br />
zidovudini + lamivudini +<br />
lopinaviri/ritonaviri<br />
abakaviri + di<strong>da</strong>nozini +<br />
lopinaviri/ritonaviri<br />
an<br />
abakaviri + di<strong>da</strong>nozini +<br />
nelfinaviri<br />
abakaviri + di<strong>da</strong>nozini +<br />
nevirapini<br />
an<br />
abakaviri + di<strong>da</strong>nozini +<br />
efavirenzi<br />
* Tu bavSvs SeuZlia kafsulis ga<strong>da</strong>ylapva, xolo preparatis<br />
erTjerad doza (romelic gaTvlilia wonaze an sxeulis farTobze)<br />
Seadgens ramodenime kafsulas erTad, mas aseve SegviZlia<br />
<strong>da</strong>vuniSnoT seqvinavir/ritonaviri an indinavir/ritonaviri<br />
6.reabilitacia <strong>da</strong> <strong>da</strong>kvirveba<br />
monitoringi samizneebi<br />
Semowmebis<br />
va<strong>da</strong><br />
anTropometruli<br />
monacemebi<br />
Semowmeba<br />
laboratoriuli<br />
gamokvlevebi<br />
142
Change language